Literature DB >> 9532993

Pregnancy in women with von Willebrand's disease or factor XI deficiency.

R A Kadir1, C A Lee, C A Sabin, D Pollard, D L Economides.   

Abstract

OBJECTIVE: To assess the obstetric outcome in women with von Willebrand's disease or factor XI deficiency.
SETTING: Haemophilia Centre and Haemostasis Unit, The Royal Free Hospital. POPULATION: Women with von Willebrand's disease (n = 31) and with factor XI deficiency (n = 11) registered at the Royal Free Hospital Haemophilia Centre who had had a pregnancy within the previous 17 years (1980-1996), including 84 in women with von Willebrand's disease and 28 in women with factor XI deficiency.
METHODS: Women were interviewed and details of the obstetric history were obtained. The records of the Haemophilia Centre and the women's maternity records were also reviewed.
RESULTS: Threatened miscarriage occurred in 33% and 14% of pregnancies with von Willebrand's disease and factor XI deficiency, respectively. Excluding recurrent miscarriages, 14/68 (21%) of pregnancies with von Willebrand's disease and one pregnancy with factor XI deficiency miscarried spontaneously. There was an increased incidence of primary and secondary post-abortal bleeding complications. Factor VIII and von Willebrand factor antigen and activity levels increased significantly in pregnancy in all women apart from those with severe von Willebrand's disease. Factor XI, however, did not show any significant change. No neonatal haemorrhagic complications in association with the birth process were reported, although ventouse and difficult forceps deliveries were avoided. Extensive perineal bruising and haematoma was reported in three women with von Willebrand's disease; two of these were associated with forceps delivery. The incidence of primary postpartum haemorrhage was 18.5% in von Willebrand's disease and 16% in factor XI deficiency. Blood transfusion was required in six cases of von Willebrand's disease and two cases of factor XI deficiency. Ten of fourteen instances of primary postpartum haemorrhage occurred when maternal factor levels were < 50 IU/dL with no prophylactic treatment for labour. The incidence of secondary postpartum haemorrhage was 20% in von Willebrand's disease and 24% in factor XI deficiency. None of the women who had prophylactic treatment during labour or the puerperium suffered any significant bleeding complications. There were three neonatal bleeding complications.
CONCLUSION: Pregnancy, labour and the puerperium are associated with significant bleeding problems in women with von Willebrand's disease or factor XI deficiency, but these are largely preventable. Specialist obstetric care in close liaison with the haemophilia centre is essential to minimise maternal and neonatal complications.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9532993     DOI: 10.1111/j.1471-0528.1998.tb10093.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  33 in total

1.  Bleeding disorders, menorrhagia and iron deficiency: impacts on health-related quality of life.

Authors:  C Rae; W Furlong; J Horsman; E Pullenayegum; C Demers; J St-Louis; D Lillicrap; R Barr
Journal:  Haemophilia       Date:  2012-09-21       Impact factor: 4.287

Review 2.  Molecular genetics of type 2 von Willebrand disease.

Authors:  Edith Fressinaud; Claudine Mazurier; Dominique Meyer
Journal:  Int J Hematol       Date:  2002-01       Impact factor: 2.490

3.  Patterns of recurrence of postpartum hemorrhage in a large population-based cohort.

Authors:  Anna Sara Oberg; Sonia Hernandez-Diaz; Kristin Palmsten; Catarina Almqvist; Brian T Bateman
Journal:  Am J Obstet Gynecol       Date:  2013-10-26       Impact factor: 8.661

4.  Antifibrinolytic therapy for preventing VWD-related postpartum hemorrhage: indications and limitations.

Authors:  Peter A Kouides
Journal:  Blood Adv       Date:  2017-04-25

5.  Molecular and clinical profile of type 2 von Willebrand disease in Iran: a thirteen-year experience.

Authors:  Maryam Rassoulzadegan; Fereydoun Ala; Mohammad Jazebi; Mohammad Said Enayat; Shadi Tabibian; Mahmood Shams; Mehran Bahraini; Akbar Dorgalaleh
Journal:  Int J Hematol       Date:  2020-01-14       Impact factor: 2.490

6.  ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease.

Authors:  Nathan T Connell; Veronica H Flood; Romina Brignardello-Petersen; Rezan Abdul-Kadir; Alice Arapshian; Susie Couper; Jean M Grow; Peter Kouides; Michael Laffan; Michelle Lavin; Frank W G Leebeek; Sarah H O'Brien; Margareth C Ozelo; Alberto Tosetto; Angela C Weyand; Paula D James; Mohamad A Kalot; Nedaa Husainat; Reem A Mustafa
Journal:  Blood Adv       Date:  2021-01-12

7.  The clinical management of factor XI deficiency in pregnant women.

Authors:  Allison P Wheeler; Celeste Hemingway; David Gailani
Journal:  Expert Rev Hematol       Date:  2020-06-12       Impact factor: 2.929

8.  Uneventful cesarean delivery with administration of factor XI concentrate in a patient with severe factor XI deficiency.

Authors:  Georgios Mavromatidis; Konstantinos Dinas; Dimitrios Delkos; Fotios Goutzioulis; Christos Vosnakis; Emmanouel Hatzipantelis; Vassilia Garipidou; David Rousso
Journal:  Int J Hematol       Date:  2007-10       Impact factor: 2.490

9.  Pregnancy and delivery in women with von Willebrand's disease and different von Willebrand factor mutations.

Authors:  Giancarlo Castaman; Alberto Tosetto; Francesco Rodeghiero
Journal:  Haematologica       Date:  2009-11-30       Impact factor: 9.941

Review 10.  Principles of care for the diagnosis and treatment of von Willebrand disease.

Authors:  Giancarlo Castaman; Anne Goodeve; Jeroen Eikenboom
Journal:  Haematologica       Date:  2013-05       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.